Trusted Resource for Clinical Trials, Protocols & Progress
Clinical trial audits, whether conducted by sponsors, CROs, or regulatory authorities like the FDA or EMA, are crucial events that assess compliance, data integrity, and subject protection. An unprepared site can face serious consequences — from critical findings and CAPAs to loss of credibility and trial exclusion.
Click to read the full article.
Archiving clinical trial documentation is not merely a final step—it is a continuous quality management process that supports inspection readiness and long-term GCP compliance. Poor archiving practices can result in critical findings, incomplete trial histories, and regulatory citations. Whether you’re handling a Trial Master File (TMF), Investigator Site File (ISF), or source records, establishing a structured archiving strategy is essential.
Click to read the full article.
Mock audits are controlled simulations of regulatory inspections, designed to assess a site’s preparedness, identify compliance gaps, and train staff for real-world audits. With rising scrutiny from agencies like the FDA and EMA, clinical sites and sponsors increasingly rely on mock audits to fine-tune their systems and responses.
Click to read the full article.
Inspection day is one of the most critical events in a clinical trial’s lifecycle. Whether it’s a routine FDA inspection, a triggered EMA visit, or a sponsor audit, the behavior and preparedness of site staff can significantly impact audit outcomes. Even the most compliant sites can falter if the personnel interacting with inspectors are untrained or inconsistent.
Click to read the full article.
In clinical trial audits and inspections, your response in the moment can make or break the auditor’s perception of site control and compliance. Regulatory inspectors often judge not just the documentation, but also how confidently and transparently site personnel handle questions. The ability to respond accurately, calmly, and concisely to queries is a critical skill for all key staff including Principal Investigators (PIs), QA leads, and site coordinators.
Click to read the full article.
Regulatory inspectors from agencies such as the FDA, EMA, and MHRA do not rely solely on checklists. Instead, they use risk-based assessments and pattern recognition to spot red flags that suggest deeper noncompliance or systemic issues. Understanding what typically triggers auditor attention helps sites proactively mitigate risk and demonstrate control.
Click to read the full article.
When preparing for clinical trial audits, many sites focus on SOPs, logs, and ICFs — yet the most critical audit findings often stem from inconsistencies in trial data. Inspectors from the FDA, EMA, or sponsor organizations expect that data presented in Case Report Forms (CRFs), electronic data capture (EDC) systems, and source documents match precisely. Even small discrepancies raise questions about site control, data integrity, and potential fraud.
Click to read the full article.
The Trial Master File (TMF) is the central repository of essential clinical trial documents. Regulatory inspectors—from the FDA, EMA, MHRA, or sponsor QA teams—use the TMF to assess trial compliance, data integrity, and documentation control. A disorganized, incomplete, or outdated TMF is a major audit red flag and often leads to critical observations.
Click to read the full article.
Audit trails serve as the digital fingerprint of clinical trial activity. They provide a chronological, tamper-proof record of who did what, when, and why. Regulatory bodies such as the FDA, EMA, and MHRA increasingly scrutinize audit trails during inspections to assess data integrity, traceability, and compliance with ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate).
Click to read the full article.
In clinical research, audits and inspections by regulatory authorities such as the FDA, EMA, or sponsor organizations are inevitable. The success of these inspections often hinges on the proactive involvement of Quality Assurance (QA) Managers, who serve as the bridge between operational teams and compliance requirements. From establishing SOPs to pre-audit reviews and mock inspections, QA managers guide teams in aligning with GCP, ICH, and other regulatory frameworks.
Click to read the full article.
